Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rapt Therapeutics Inc
(NQ:
RAPT
)
1.155
-0.105 (-8.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Rapt Therapeutics Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 11, 2024
Via
Benzinga
Crude Oil Down 3%; Aramark Posts Upbeat Earnings
November 11, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Moves Lower; Canaan Shares Surge
November 11, 2024
Via
Benzinga
Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury
November 11, 2024
RAPT Therapeutics stock falls after halting its zelnecirnon program following FDA clinical hold. Company shifts focus.
Via
Benzinga
Exposures
Product Safety
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
November 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
RAPT Therapeutics: Q4 Earnings Insights
March 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 06, 2024
Via
Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
November 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 02, 2024
Via
Benzinga
RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q2 2024
August 08, 2024
RAPT stock results show that RAPT Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
June 03, 2024
Via
Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
May 21, 2024
Via
Benzinga
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
May 09, 2024
RAPT Therapeutics closes Phase 2 trials for zelnecirnon in atopic dermatitis & asthma following FDA clinical hold due to liver failure.
Via
Benzinga
Exposures
Product Safety
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 09, 2024
Via
Benzinga
RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q1 2024
May 09, 2024
RAPT stock results show that RAPT Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
3 Biotech Stocks to Dump Before They Go to Zero
April 09, 2024
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling.
Via
InvestorPlace
RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q4 2023
March 07, 2024
RAPT stock results show that RAPT Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Rivian Automotive Reports Q4 Loss, Joins Etsy, Lucid Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 22, 2024
U.S. stock futures were higher this morning, with the Nasdaq futures trading higher by around 2% on Thursday.
Via
Benzinga
What's Going On With RAPT Therapeutics Stock On Wednesday?
February 21, 2024
Latest developments in RAPT Therapeutics as FDA places clinical hold on Phase 2b trial for zelnecirnon in dermatitis and asthma. Stock rebounds and analyst downgrades.
Via
Benzinga
Exposures
Product Safety
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 21, 2024
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 21, 2024
Via
Benzinga
Stocks Slip Ahead Of Fed Minutes, Nvidia Earnings
February 21, 2024
Stocks are lower today, with the Nasdaq Composite Index (IXIC) leading the losses as investors reassess a potentially overvalued tech sector.
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
February 20, 2024
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 20, 2024
Via
Benzinga
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
February 20, 2024
FDA places clinical hold on RAPT Therapeutics' Phase 2 trials for zelnecirnon in atopic dermatitis and asthma.
Via
Benzinga
Exposures
Product Safety
Rapt Therapeutics Crashes 65% After Unexpected Liver Failure Sidelines Two Tests
February 20, 2024
The FDA put studies in eczema and asthma treatment on clinical hold.
Via
Investor's Business Daily
Exposures
Product Safety
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 20, 2024
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Via
Benzinga
Dow Dips Over 100 Points; US Leading Economic Index Falls In January
February 20, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Rebounds; Nasdaq Drops Triple Digits
February 20, 2024
Nvidia stock is sliding ahead of tomorrow's earnings report
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.